AI assistant
Sending…
Arctic Bioscience — Director's Dealing 2023
Feb 23, 2023
3536_dirs_2023-02-23_ddd16b00-4bd1-44d8-952a-8d577b3e4b6d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3: Notification template for notifying transactions
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Runhild Gammelsæter | |
| 2 | Reason for the notification | ||
| a) | Position/status | Medical Director in Arctic Bioscience | |
| b) | Initial notification / Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
| a) | Name | Arctic Bioscience AS | |
| Industriveien 42, 6155 Ørsta | |||
| b) | LEI | 549300Z2HW6I989Q2C78 | |
| 4 | Details of the transaction(s): section to the repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
| a) | Description of the financial instrument, type of instrument Identification code |
Stock in Arctic Bioscience NO0010859580 |
|
| b) | Nature of the transaction | Stock purchase | |
| c) | Price(s) and volume(s) | Price(s): 13,9 |
Volume(s): 11500 |
| d) | Aggregated information | - 11500 |
|
| - Aggregated volume |
- 13,9 |
||
| - Price |
|||
| e) | Date of the transaction | February 23rd 2023 | |
| f) | Place of the transaction | MERK - Euronext Growth |
More from Arctic Bioscience
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7